Galderma Laboratories Announces the National Launch of qilib™, a Breakthrough, New Hair Care Line Created to Regrow, Revitalize and Improve Hair Health

qilib Offers Men and Women Effective Solutions with Clinically Proven
Minoxidil and Natural Botanical Ingredients

FT. WORTH, Texas–(BUSINESS WIRE)–Galderma
Laboratories, L.P., a global leader focused on medical solutions in
dermatology and skin health and the maker of Cetaphil®, today announced
the launch and nationwide availability of qilib™
Hair Regrowth + Revitalization System and qilib™
Hair Health Reinforcement Biotin + Multivitamin Supplement.
Leveraging the company’s expertise and history in skin health, the qilib
portfolio features a breakthrough, dual action system to address hair
thinning and hair loss. Despite the 80 million men and women in the US
who suffer from hair loss, there has been little innovation since
minoxidil was approved for over the counter use nearly 20 years ago.

“The qilib Hair Regrowth + Revitalization System is a game changer
because it showed clinical results in both men and women in as early as
4 weeks,” says Amy McMichael, M.D., board-certified dermatologist and
Professor and Chair of Dermatology at Wake Forest University School of
Medicine. “For men and women frustrated with their current hair loss
treatments, I encourage them to try qilib and see for themselves what a
difference it can make to their hair.”

The qilib system is made of up the Hair Regrowth Treatment, which
contains clinically proven, prescription-strength minoxidil specifically
formulated for men (5% minoxidil) or women (2% minoxidil), and the Hair
Revitalizing Solution formulated with natural botanicals. The Hair
Regrowth Treatment works by helping to awaken and restore dormant hair
follicles so new hair can grow again, while the qilib™ Hair Revitalizing
Solution nourishes the skin of the scalp with natural botanical
ingredients, vitamin C, proteins, lipids and antioxidants. When used as
directed, 70% of male and more than 75% of female participants were
“satisfied with overall improvement” at 12 weeks of use. Both the Hair
Regrowth Treatment and the Hair Revitalizing Solution come in an
easy-to-use spray bottle.

“Delivering innovative solutions to improve people’s health and
self-confidence is a core value at Galderma,” says Miles Harrison,
President and General Manager of Galderma Laboratories, L.P. “qilib’s
launch embodies our pioneering approach to address skin care issues,
including those associated with the hair and scalp, with solutions
backed by science. The millions of sufferers of thinning hair and hair
loss have had limited options that work, but now, qilib Hair Regrowth +
Revitalization System is available to provide fast, visible results in
as little as 4 weeks.”

qilib™ Hair Health Reinforcement Biotin + Multivitamin Supplement is
made up of 5,000 mcg biotin, a key ingredient to help support healthy
hair and scalp, and multiple vitamins, including the daily recommended
dose of Vitamins B12, C, D3, E.¹ Developed in partnership
with, and tested by dermatologists, both qilib™ Hair Regrowth +
Revitalization System and qilib™ Hair Health Reinforcement Biotin +
Multivitamin Supplement are suitable for any hair type.

About qilib

qilib™ Hair Regrowth + Revitalization System (manufacturer suggested
retail price (MSRP) of $45.99 for a one month supply) and qilib Hair
Health Reinforcement Biotin + Multivitamin Supplement (MSRP $9.99 for 30
tablets and $16.99 for 90 tablets) is currently available in CVS,
Walgreen’s,
Target,
Amazon.com,
Drugstore.com,
and will soon be offered at Walmart. The components of the qilib™ Hair
Regrowth + Revitalization System, the Hair Regrowth Treatment (MSRP
$22.49) and Hair Revitalization Solution (MSRP $33.99) are also
available for purchase separately.

For more information, visit qilib.us.

About Hair Loss

In the U.S., over 80 million men and women experience hair loss. Almost
half of all women experience pattern hair loss, also known as androgenic
alopecia, at some point in their lives. About two-thirds of men
experience pattern hair loss by the time they reach 35. Primary causes
of hair loss include certain medications, genetics, the change in
hormones during and after pregnancy (for women), thyroid disorders and
anemia. Autoimmune disorders (e.g. psoriasis, seborrheic dermatitis),
extreme stress, physical trauma, and dramatic weight loss can also
trigger hair loss.

About Galderma

Dating back to 1961, Galderma is now present in 100 countries with an
extensive product portfolio to treat a range of dermatological
conditions. The company partners with health care professionals around
the world to meet the skin health needs of people throughout their
lifetime. Galderma is a leader in research and development of
scientifically-defined and medically-proven solutions for the skin, hair
and nails.

Strategic brands in the U.S. include Epiduo® Gel, Epiduo® Forte
Gel, Oracea® Capsules, Clobex® Spray, Differin® Gel, Mirvaso® Gel,
MetroGel® Gel, Soolantra® Cream, Vectical® Cream, Tri-Luma® Cream,
Cetaphil®, Benzac® Acne Solutions, Restylane®, Restylane® Silk,
Restylane® Lyft, Dysport® (abobotulinumtoxinA) and Sculptra® Aesthetic.

For more information, please visit www.galderma.com
and www.galdermausa.com.

¹ These statements have not been evaluated by the Food and
Drug Administration. This product is not intended to diagnose, treat,
cure or prevent any disease.

Contacts

Galderma
Virginie Naigeon
Director of Corporate
Communications, U.S.
virginie.naigeon@galderma.com
or
Twist
Mktg
Amanda Loder, 212-259-0491
aloder@w2ogroup.com